Katusha-Alpecin's Tony Martin has retracted comments he made about Chris Froome and the UCI after he slammed both parties earlier this week.
Froome was found to have had double the allowed amount of the asthma medication Salbutamol in his system following a urine test at this year's Vuelta a Espana.
Following the revelations, Martin voiced his anger that the Brit was allowed to compete at September's World Championships in spite of the adverse test, describing the episode as a 'scandal' and suggesting that cycling's governing body was showing favouritism towards the Team Sky rider.
The German, who is a five-time stage winner at the Tour de France, also went on to state that the UCI's "double standards" were "a major blow to the difficult anti-doping fight."
However, Martin, 32, has now changed his stance on the incident, stating: "I now understand that the UCI is managing this case in accordance with the rules and that Chris Froome did not get any special treatment.
"According to the rules, in a case involving a specified substance, every athlete shall have the chance to explain whether the numbers can be due to natural causes."
"I will always remain an outspoken advocate for a 100 percent clean sport," the four-time world time trial champion added on Saturday.
Martin is not the only one of Froome's rivals to have their say on the matter.
"We really could have done without it [the controversy]," said AG2R rider Romain Bardet, who finished third at this year's Tour de France. "It's not something anyone can rejoice about.
"Let's hope that a swift and objective probe can clarify the facts and leave no doubts about what happened."